Klinik Araştırma

A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia

Cilt: 5 Sayı: 3 15 Aralık 2022
PDF İndir
EN

A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia

Öz

This study evaluated cases of spontaneous pneumothorax developing secondary to SARS-CoV-2 pneumonia. Sixteen cases presenting to our hospital due to spontaneous pneumothorax developing secondary to SARS-CoV-2 pneumonia between March 2020 and February 2020 were evaluated retrospectively. Ten patients (62.5%) were men, and six (37.5%) were women, with a mean age of 68 ± 20.3 years (range 18 - 90 years). Pneumothorax was in the right hemithorax in 11 cases (68.75%), in the left hemithorax in two (12.5%), and bilateral in three (17.75%). Pneumothorax developed during active SARS-CoV-2 pneumonia in all 16 cases (100%). No pneumothorax was detected following the healing of SARS-CoV-2 infection. Pneumothorax was observed while patients were not intubated in 15 cases (93.75%), but pneumothorax developed during mechanical ventilation in one case (6.25%). Tube thoracostomy was performed on all patients in treatment. Air leakage from the tube was observed in 14 cases (87.5%). The mean duration of tube thoracostomy was 18.3 ± 20.1 days (range 1 - 81 days). Pneumothorax resolved after treatment in seven cases (43.75%), while mortality occurred in nine (56.25%). Pneumothorax recurred after treatment in one case (6.25%). Pneumothorax is widely seen in the active period or after healing in cases infected with COVID-19. Aggressive treatment is generally required for this clinical manifestation with high mortality.

Anahtar Kelimeler

Destekleyen Kurum

yok

Kaynakça

  1. 1. Onuki T, Ueda S, Yamaoka M, Sekiya Y, Yamada H, Kawakami N, et al. Primary and Secondary Spontaneous Pneumothorax: Prevalence, Clinical Features, and In-Hospital Mortality. Can Respir J. 2017;2017:6014967.
  2. 2. Türkyılmaz A, Erdem AF, Aydın Y, Çinici Ö, Eroğlu A. Treatment of Secondary Spontaneous Pneumothorax: 100-Patient Experience. The Eurasian Journal of Medicine 2007; 39: 97-102. (Turkish).
  3. 3. Elhakim TS, Abdul HS, Pelaez Romero C, Rodriguez-Fuentes Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review. BMJ Case Rep. 2020;13:e239489.
  4. 4. Quincho-Lopez A, Quincho-Lopez DL, Hurtado-Medina FD. Case Report: Pneumothorax and Pneumomediastinum as Uncommon Complications of COVID-19 Pneumonia-Literature Review. Am J Trop Med Hyg. 2020;103:1170-1176.
  5. 5. Alhakeem A, Khan MM, Al Soub H, Yousaf Z. Case Report: COVID-19-Associated Bilateral Spontaneous Pneumothorax-A Literature Review. Am J Trop Med Hyg. 2020;103:1162-1165.
  6. 6. Miró Ò, Llorens P, Jiménez S, Piñera P, Burillo-Putze G, Martín A, et al. Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019: A Case-Control, Emergency Medicine-Based Multicenter Study. Chest. 2021;159:1241-1255.
  7. 7. Rafiee MJ, Babaki Fard F, Samimi K, Rasti H, Pressacco J. Spontaneous pneumothorax and pneumomediastinum as a rare complication of COVID-19 pneumonia: Report of 6 cases. Radiol Case Rep. 2021;16:687-692.
  8. 8. Akçay Ş, Özlü T, Yılmaz A. Radiological approaches to COVID-19 pneumonia. Turk J Med Sci. 2020;50:604-610.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Mikrobiyoloji

Bölüm

Klinik Araştırma

Yayımlanma Tarihi

15 Aralık 2022

Gönderilme Tarihi

13 Mayıs 2022

Kabul Tarihi

8 Ağustos 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 5 Sayı: 3

Kaynak Göster

APA
Taş, N., Naldan, M., Öner, F., Naldan, H., & Aydin, Y. (2022). A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. International Journal of Life Sciences and Biotechnology, 5(3), 562-571. https://doi.org/10.38001/ijlsb.1116153
AMA
1.Taş N, Naldan M, Öner F, Naldan H, Aydin Y. A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. Int J. Life Sci. Biotechnol. 2022;5(3):562-571. doi:10.38001/ijlsb.1116153
Chicago
Taş, Nurmuhammet, Muhammet Naldan, Fatih Öner, Hülya Naldan, ve Yener Aydin. 2022. “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”. International Journal of Life Sciences and Biotechnology 5 (3): 562-71. https://doi.org/10.38001/ijlsb.1116153.
EndNote
Taş N, Naldan M, Öner F, Naldan H, Aydin Y (01 Aralık 2022) A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. International Journal of Life Sciences and Biotechnology 5 3 562–571.
IEEE
[1]N. Taş, M. Naldan, F. Öner, H. Naldan, ve Y. Aydin, “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”, Int J. Life Sci. Biotechnol., c. 5, sy 3, ss. 562–571, Ara. 2022, doi: 10.38001/ijlsb.1116153.
ISNAD
Taş, Nurmuhammet - Naldan, Muhammet - Öner, Fatih - Naldan, Hülya - Aydin, Yener. “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”. International Journal of Life Sciences and Biotechnology 5/3 (01 Aralık 2022): 562-571. https://doi.org/10.38001/ijlsb.1116153.
JAMA
1.Taş N, Naldan M, Öner F, Naldan H, Aydin Y. A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. Int J. Life Sci. Biotechnol. 2022;5:562–571.
MLA
Taş, Nurmuhammet, vd. “A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia”. International Journal of Life Sciences and Biotechnology, c. 5, sy 3, Aralık 2022, ss. 562-71, doi:10.38001/ijlsb.1116153.
Vancouver
1.Nurmuhammet Taş, Muhammet Naldan, Fatih Öner, Hülya Naldan, Yener Aydin. A Current and Common Cause of Secondary Spontaneous Pneumothorax: Covid- 19 Pneumonia. Int J. Life Sci. Biotechnol. 01 Aralık 2022;5(3):562-71. doi:10.38001/ijlsb.1116153


Sosyal ağlarda bizi takip edin   19277 19276 20153 22366